About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Melanoma Clinical Trials | 3,341 Studies Recruiting

Clinical TrialsMelanoma

Melanoma Clinical Trials

Browse 3,341 clinical trials for melanoma. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 361-380 of 3,341 trials

UnknownClinical vAlidation of a MobilE appLication ("ProRodinki") in the Assessment of the maLignant skIn neoplAsmsA Multicenter, Prospective, Low-interventional Clinical Study Evaluating on mobile application validation ("ProRodinki") in assessing the risk of skin malignant neoplasmsNCT05402046·Moscow and 1 other CompletedTumor-Infiltrating Lymphocytes And Low-Dose Interleukin-2 Therapy Following Cyclophosphamide And Fludarabine In Patients With MelanomaThis is a phase II clinical study for patients with metastatic (the cancer has spread to other parts of the body) melanoma.NCT01883323·Toronto, Ontario TerminatedPrecise DCE-MRI in Diagnosing Participants With Recurrent High Grade Glioma or Melanoma Brain MetastasesDynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) is a potentially powerful diagnostic tool for the management of brain cancer and other conditions in which the…NCT03698162·Los Angeles, California

Related Searches

skin cancertrials

Data from ClinicalTrials.govTerms

RecruitingLymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or MelanomaThis pilot trial studies whether a procedure called lymphovenous bypass would prevent lymphedema (arm swelling) in patients with inflammatory breast cancer or non-inflammatory…NCT03941756·Houston, Texas

CompletedVaccine Biotherapy of Cancer: Autologous Tumor Cells and Dendritic CellsThis protocol was conducted as a single institution trial at Hoag Cancer Center, Hoag Hospital, Newport Beach, California.NCT00948480·Newport Beach, California

RecruitingACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid TumorsThe study's purpose is to establish the safety and tolerability of IMA203/IMA203CD8 products with or without combination with nivolumab in patients with solid tumors that express…NCT03686124·Stanford, California and 20 others

TerminatedPROCLAIM: CX-072-002: Study of PD-L1 Probody Therapeutic CX-072 in Combination With Other Anticancer Therapy in Adults With Solid TumorsTo obtain evidence of antitumor effect of CX-072 in combination with anticancer therapy in adult patients with solid tumor based upon overall response rate by Response Evaluation…NCT03993379·Duarte, California and 26 others

Active not recruitingZr89 + PET Companion TrialStudy of Zirconium Zr 89 Crefmirlimab Berdoxa PET/CT as an imaging biomarker for assessing an early response to therapy in patients with advanced melanoma on immunotherapy and…NCT05279027·Philadelphia, Pennsylvania

UnknownWhole Brain Radiotherapy Following Local Treatment of Intracranial Metastases of MelanomaPeople with brain metastases from melanoma are offered different treatment options after local treatment of their brain metastases via surgery or stereotactic irradiation.NCT01503827·Darlinghurst, New South Wales and 22 others

CompletedPhase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare DiseasesExploratory study to examine the effect(s) of Imatinib mesylate treatment on life threatening rare diseases with known associations to one or more Imatinib mesylate -sensitive…NCT00154388

Active not recruitingStudy of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 MutationsThis is an open-label, multicenter Phase 1 study to evaluate safety, tolerability and preliminary efficacy of oral LY3410738 in patients with isocitrate dehydrogenase 1 (IDH1)…NCT04521686·Phoenix, Arizona and 32 others

CompletedComparative Effectiveness of Targeted Therapies in BRAF Positive Metastatic Melanoma in the USThis study aims to compare real-world effectiveness of BRAF/MEK inhibitors in BRAF-mutant metastatic melanoma patients in the United States by line of therapy.NCT05260684·New York, New York

Not yet recruitingStudy of CD160, an Activating NK Cell Receptor, in Melanoma: a Potential Therapeutic Target?Although immunotherapy revolutionized melanoma outcomes over the last 10 years, only 40-50% of patients respond to treatments and 25% develop acquired resistances.NCT04477876

RecruitingDETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.This clinical trial is looking at two drugs called dabrafenib and trametinib.NCT07440290·Belfast and 26 others

CompletedA Phase I/II Open-Label Study of Ipilimumab and GM-CSF Administered to Unresectable Stage IIIC and Stage IV Melanoma PatientsThe purpose of this study is to test the combination of Ipilimumab and GM-CSF.NCT02009397·Louisville, Kentucky

UnknownEvaluation of Denosumab in Combination With Immune Checkpoint Inhibitors in Patients With Unresectable or Metastatic MelanomaThe purpose of this project is to test the addition of a new treatment called denosumab to standard immunotherapies for patients with metastatic melanoma.NCT03161756·Albury, New South Wales and 9 others

CompletedVaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid TumorsRATIONALE: Vaccines made from a peptide may make the body build an immune response to kill tumor cells.NCT00019331·Bethesda, Maryland

CompletedMelaMEd Online Training for General Practitioners to Improve Melanoma Detection and ManagementThe goal of this trial was to learn whether the MelaMEd online training program could improve doctors' skills in the early detection and management of melanoma, the most…NCT07757386·Avellino, Campania and 9 others

TerminatedPilot Trial of "Chemo-Switch" Regimen to Treat Advanced MelanomaThis research study is testing the "chemo-switch" strategy in melanoma, using biochemotherapy initially to shrink tumors and then switching to daily low-dose chemotherapy…NCT00673361

CompletedSafety Study of KPT-330 (Selinexor) in Patients With Advanced or Metastatic Solid Tumor CancerPhase 1 study to evaluate the safety and tolerability of selinexor and determine the Recommended Phase 2 Dose (RP2D) of selinexor for advanced or metastatic solid tumor…NCT01607905·Tampa, Florida and 5 others

PreviousPage 19 of 168Next